vs

Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and RENASANT CORP (RNST). Click either name above to swap in a different company.

Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $273.8M, roughly 1.5× RENASANT CORP). RENASANT CORP runs the higher net margin — 32.2% vs 5.3%, a 27.0% gap on every dollar of revenue.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

Renasant Bank is an American regional commercial financial institution based in Tupelo, Mississippi. The bank has more than 280 branches in Alabama, Florida, Georgia, Mississippi, Louisiana, Tennessee, North Carolina and South Carolina. Renasant Bank operates under the parent company Renasant Corporation and is affiliated with Renasant Nation, a platform through which they publish blogs and shows.

GRDN vs RNST — Head-to-Head

Bigger by revenue
GRDN
GRDN
1.5× larger
GRDN
$397.6M
$273.8M
RNST
Higher net margin
RNST
RNST
27.0% more per $
RNST
32.2%
5.3%
GRDN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GRDN
GRDN
RNST
RNST
Revenue
$397.6M
$273.8M
Net Profit
$20.9M
$88.2M
Gross Margin
21.5%
Operating Margin
7.7%
Net Margin
5.3%
32.2%
Revenue YoY
Net Profit YoY
112.5%
EPS (diluted)
$0.94

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRDN
GRDN
RNST
RNST
Q1 26
$273.8M
Q4 25
$397.6M
$278.4M
Q3 25
$377.4M
$269.5M
Q2 25
$344.3M
$267.2M
Q1 25
$329.3M
$170.7M
Q4 24
$167.1M
Q3 24
$314.4M
$220.3M
Q2 24
$163.8M
Net Profit
GRDN
GRDN
RNST
RNST
Q1 26
$88.2M
Q4 25
$20.9M
$78.9M
Q3 25
$9.8M
$59.8M
Q2 25
$9.0M
$1.0M
Q1 25
$9.4M
$41.5M
Q4 24
$44.7M
Q3 24
$-122.0M
$72.5M
Q2 24
$38.8M
Gross Margin
GRDN
GRDN
RNST
RNST
Q1 26
Q4 25
21.5%
Q3 25
19.8%
Q2 25
19.8%
Q1 25
19.5%
Q4 24
Q3 24
19.4%
Q2 24
Operating Margin
GRDN
GRDN
RNST
RNST
Q1 26
Q4 25
7.7%
34.8%
Q3 25
4.3%
27.9%
Q2 25
3.7%
1.0%
Q1 25
3.9%
30.4%
Q4 24
29.8%
Q3 24
-33.3%
44.2%
Q2 24
29.6%
Net Margin
GRDN
GRDN
RNST
RNST
Q1 26
32.2%
Q4 25
5.3%
28.4%
Q3 25
2.6%
22.2%
Q2 25
2.6%
0.4%
Q1 25
2.9%
24.3%
Q4 24
26.8%
Q3 24
-38.8%
32.9%
Q2 24
23.7%
EPS (diluted)
GRDN
GRDN
RNST
RNST
Q1 26
$0.94
Q4 25
$0.78
Q3 25
$0.63
Q2 25
$0.01
Q1 25
$0.65
Q4 24
$0.70
Q3 24
$1.18
Q2 24
$0.69

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRDN
GRDN
RNST
RNST
Cash + ST InvestmentsLiquidity on hand
$65.6M
$1.2B
Total DebtLower is stronger
$0
$806.2M
Stockholders' EquityBook value
$217.9M
$3.9B
Total Assets
$412.7M
$27.1B
Debt / EquityLower = less leverage
0.00×
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRDN
GRDN
RNST
RNST
Q1 26
$1.2B
Q4 25
$65.6M
$1.1B
Q3 25
$36.5M
$1.1B
Q2 25
$18.8M
$1.4B
Q1 25
$14.0M
$1.1B
Q4 24
$1.1B
Q3 24
$37.2M
$1.3B
Q2 24
$851.9M
Total Debt
GRDN
GRDN
RNST
RNST
Q1 26
$806.2M
Q4 25
$0
$499.8M
Q3 25
$558.9M
Q2 25
$557.0M
Q1 25
$433.3M
Q4 24
$430.6M
Q3 24
$34.3M
$433.2M
Q2 24
$428.7M
Stockholders' Equity
GRDN
GRDN
RNST
RNST
Q1 26
$3.9B
Q4 25
$217.9M
$3.9B
Q3 25
$195.5M
$3.8B
Q2 25
$179.7M
$3.8B
Q1 25
$163.2M
$2.7B
Q4 24
$2.7B
Q3 24
$133.9M
$2.7B
Q2 24
$2.4B
Total Assets
GRDN
GRDN
RNST
RNST
Q1 26
$27.1B
Q4 25
$412.7M
$26.8B
Q3 25
$390.0M
$26.7B
Q2 25
$356.3M
$26.6B
Q1 25
$334.0M
$18.3B
Q4 24
$18.0B
Q3 24
$348.0M
$18.0B
Q2 24
$17.5B
Debt / Equity
GRDN
GRDN
RNST
RNST
Q1 26
0.21×
Q4 25
0.00×
0.13×
Q3 25
0.15×
Q2 25
0.15×
Q1 25
0.16×
Q4 24
0.16×
Q3 24
0.26×
0.16×
Q2 24
0.18×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRDN
GRDN
RNST
RNST
Operating Cash FlowLast quarter
$34.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRDN
GRDN
RNST
RNST
Q1 26
Q4 25
$34.6M
$271.5M
Q3 25
$28.2M
$135.5M
Q2 25
$19.9M
$-77.3M
Q1 25
$17.6M
$106.2M
Q4 24
$106.4M
Q3 24
$-1.7M
Q2 24
$-49.1M
Free Cash Flow
GRDN
GRDN
RNST
RNST
Q1 26
Q4 25
$237.8M
Q3 25
$24.2M
$120.1M
Q2 25
$-87.5M
Q1 25
$101.3M
Q4 24
$92.8M
Q3 24
$-5.3M
Q2 24
$-52.6M
FCF Margin
GRDN
GRDN
RNST
RNST
Q1 26
Q4 25
85.4%
Q3 25
6.4%
44.6%
Q2 25
-32.7%
Q1 25
59.4%
Q4 24
55.5%
Q3 24
-2.4%
Q2 24
-32.1%
Capex Intensity
GRDN
GRDN
RNST
RNST
Q1 26
Q4 25
12.1%
Q3 25
1.1%
5.7%
Q2 25
3.8%
Q1 25
2.8%
Q4 24
8.2%
Q3 24
1.6%
Q2 24
2.1%
Cash Conversion
GRDN
GRDN
RNST
RNST
Q1 26
Q4 25
1.65×
3.44×
Q3 25
2.87×
2.27×
Q2 25
2.21×
-75.92×
Q1 25
1.86×
2.56×
Q4 24
2.38×
Q3 24
-0.02×
Q2 24
-1.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRDN
GRDN

Segment breakdown not available.

RNST
RNST

Net Interest Income$223.6M82%
Noninterest Income$50.3M18%

Related Comparisons